Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)

医学 围手术期 肺癌 外科 随机对照试验 生活质量(医疗保健) 前瞻性队列研究 阶段(地层学) 内科学 古生物学 护理部 生物
作者
Georgios Stamatis,Gunda Leschber,Birte Schwarz,Diana Lütke Brintrup,Claudia Ose,Gerhard Weinreich,Bernward Passlick,E. Hecker,Christian Kügler,Hendrik Dienemann,Thomas Krbek,Stephan Eggeling,Rudolf Hatz,Michael Müller,Walter Weder,Clemens Aigner,Karl‐Heinz Jöckel
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:138: 19-26 被引量:72
标识
DOI:10.1016/j.lungcan.2019.09.021
摘要

Objectives For early stage non-small cell lung cancer (NSCLC) retrospective data of functionally compromised patients undergoing segmentectomy showed equal outcomes for perioperative complications and quality of life (QoL) compared with lobectomy patients. However no prospectively randomized data comparing patients eligible for both procedures are available. Materials and methods We conducted a prospective, randomized, multicenter phase III trial and investigated perioperative complications and QoL in patients with NSCLC stage IA (7th edition) undergoing segmentectomy versus lobectomy. The EORTC Questionnaire Core-30 (QLQ C-30) supplemented by thirteen-item lung cancer-specific module (LC13) was assessed before surgery, at discharge, 6 weeks, 3, 6 and 12 months post-surgery. Results 108 patients with verified or suspected NSCLC up to 2 cm diameter were enrolled, whereby 54 were assigned to lobectomy and 54 to segmentectomy. Due to nodal disease, tumor size and surgical reasons estimated during the operation, eight patients of the segmentectomy group received a lobectomy. In hospital and 90 days mortality was 0% in both groups. Perioperative complications were observed in 6 (11.3%) patients after segmentectomy and in 8 patients (14.8%) after lobectomy (p = 0.563), while the 90-day morbidity were 17% and 25.9% (9 and 14 patients), respectively (p = 0.452). Twelve months after surgery, there was a significant deterioration to the baselines of physical (p < 0.001) and cognitive functioning (p = 0.025), dyspnea (p < 0.001) and fatigue (p = 0.003) in the lobectomy group. Dyspnea showed a faster recovery in the segmentectomy compared to lobectomy group with statistical significance (p = 0.016 after 12 months). Conclusion In patients with early-stage NSCLC, segmentectomy is associated with a statistically not significant lower perioperative morbidity and appears to provide a superior recovery in QoL compared with lobectomy patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
自觉的宇完成签到 ,获得积分10
刚刚
甜叶菊完成签到,获得积分10
2秒前
yaomax完成签到 ,获得积分10
3秒前
田小甜完成签到 ,获得积分10
6秒前
无花果应助抗体药物偶联采纳,获得10
12秒前
砥砺前行完成签到 ,获得积分10
15秒前
厚德载物完成签到 ,获得积分10
19秒前
小喵不上课完成签到 ,获得积分10
19秒前
白石溪完成签到,获得积分10
20秒前
聪慧啤酒完成签到 ,获得积分10
23秒前
Kiki完成签到 ,获得积分10
23秒前
25秒前
Eins完成签到 ,获得积分0
28秒前
30秒前
孙乐777完成签到,获得积分10
31秒前
岁月如歌完成签到 ,获得积分0
36秒前
Nico_Ding完成签到 ,获得积分10
36秒前
单薄的钢笔完成签到,获得积分10
39秒前
知行完成签到,获得积分0
41秒前
qqz完成签到 ,获得积分10
42秒前
吃吃喝喝求长胖完成签到,获得积分10
43秒前
44秒前
49秒前
jiaying完成签到 ,获得积分10
50秒前
文静灵阳完成签到 ,获得积分10
50秒前
晓风残月完成签到 ,获得积分10
53秒前
甜叶菊发布了新的文献求助10
54秒前
张江川完成签到,获得积分10
55秒前
善良的梦桃完成签到,获得积分10
1分钟前
奇奇怪怪的大鱼完成签到,获得积分10
1分钟前
林楚棋完成签到 ,获得积分10
1分钟前
Serein完成签到,获得积分10
1分钟前
刘艺涵完成签到 ,获得积分10
1分钟前
趙途嘵生完成签到,获得积分10
1分钟前
出厂价完成签到,获得积分10
1分钟前
1分钟前
单纯无声完成签到 ,获得积分10
1分钟前
1分钟前
Yi完成签到,获得积分10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
内視鏡的に摘除しえた十二指腸乳頭部腫瘍の2例 660
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
微电子器件实验教程 400
The Neuroscience of Language 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7677118
求助须知:如何正确求助?哪些是违规求助? 9242947
关于积分的说明 19919512
捐赠科研通 7247631
什么是DOI,文献DOI怎么找? 3286773
关于科研通互助平台的介绍 2444739
邀请新用户注册赠送积分活动 2289829